Advertisement
Research Article| Volume 16, ISSUE 1, P105-123, March 1996

The Underlying Molecular Mechanism of Apolipoprotein E Polymorphism: Relationships to Lipid Disorders, Cardiovascular Disease, and Alzheimer’s Disease

DOI:https://doi.org/10.1016/S0272-2712(18)30290-7
The Underlying Molecular Mechanism of Apolipoprotein E Polymorphism: Relationships to Lipid Disorders, Cardiovascular Disease, and Alzheimer’s Disease
Previous ArticleNASBA: A Novel, Isothermal Detection Technology for Qualitative and Quantitative HIV-1 RNA Measurements
Next ArticleMolecular Approaches for the Diagnosis of 21-Hydroxylase Deficiency and Congenital Adrenal Hyperplasia
      This paper is only available as a PDF. To read, Please Download here.
      Apolipoprotein E (apo E) polymorphism has important clinical correlates, including disorders of lipoprotein metabolism and atherosclerosis. This article provides a detailed methodology for apo E genotyping and discusses the link between apo E genotype and type III hyperlipoproteinemia, coronary heart disease (CHD), stroke, and Alzheimer’s disease (AD). Although apo E genotype appears to provide significant information concerning the genetic component of CHD and AD risk, more research is needed before genotyping can be recommended as a routine screening tool. The data so far, however, implicate apo E as a major component of the genetic basis of cardiovascular disease and AD.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Beisiegel U.
        • Weber W.
        • Ihrke G.
        The LDL-receptor-related protein, LRP, is an apolipo-protein E binding protein.
        Nature. 1989; 341: 162
        • Boerwinkle E.
        • Visvikas S.
        • Welsh D.
        The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein and triglyceride levels in a sample of unrelated individuals.
        Am J Med Genet. 1987; 27: 567
        • Boerwinkle E.
        • Utermann G.
        Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism.
        Am J Hum Genet. 1988; 42: 104
        • Boerwinkle E.
        • Brown S.A.
        • Rohrbach K.
        • et al.
        Role of apolipoprotein E and B gene variation in determining response of lipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterol.
        Am J Hum Genet. 1991; 49: 1145
        • Brown M.S.
        • Goldstein J.L.
        A receptor-mediated pathway for cholesterol homeostasis.
        Science. 1986; 232: 34
        • Carmena R.
        • Roedereer G.
        • Mailloux H.
        • et al.
        The response to lovastatin in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism.
        Metabolism. 1993; 42: 895
        • Clavel C.
        • Durlach A.
        • Durlach V.
        • et al.
        Rapid and safe determination of human apolipoprotein E genotypes by miniaturised SDS-PAGE in non-insulin dependent diabetes mellitus.
        J Clin Pathol. 1995; 48: 295
        • Cobb M.M.
        • Teitlebaum H.
        • Risch N.
        • et al.
        Influence of dietary fat, apolipoprotein E phenotype, and sex on plasma lipoprotein levels.
        Circulation. 1991; 86: 145
        • Corder E.H.
        • Saunders A.M.
        • Strittmatter W.J.
        • et al.
        Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families.
        Science. 1993; 261: 921
        • Couderc R.
        • Mahieux F.
        • Baiileul S.
        • et al.
        Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease: A case-control study.
        Stroke. 1993; 24: 661
        • Cumming A.M.
        • Robertson F.W.
        Polymorphism at the apoprotein-E locus in relation to risk of coronary disease.
        Clin Genet. 1984; 25: 310
        • Dallongeville J.
        • Lussier-Cacan S.
        • Davignon J.
        Modulation of plasma triglyceride levels by apo E phenotype: A meta-analysis.
        J Lipid Res. 1992; 33: 447
        • Davignon J.
        • Bouthillier D.
        • Nestruck A.C.
        • et al.
        Apolipoprotein E polymorphism and atherosclerosis: Insight from a study in octogenarians.
        Trans Am Clin Climatol/Assoc. 1987; 99: 100
        • Davignon J.
        • Gregg R.E.
        • Sing C.F.
        Apolipoprotein E polymorphism and atherosclerosis.
        Arteriosclerosis. 1988; 8: 1
        • DeKnijff P.
        • Stalenhoef A.F.H.
        • Mol MJTM
        • et al.
        Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia.
        Atherosclerosis. 1990; 83: 89
        • DeKnijff P.
        • van den Maagdenberg A.M.
        • Frants R.R.
        • et al.
        Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels.
        Hum Mutation. 1994; 4: 178
        • Demant T.
        • Bedford D.
        • Packard C.J.
        • et al.
        Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects.
        J Clin Invest. 1991; 88: 1490
        • Despres J.P.
        • Verdon M.
        • Moorjani S.
        • et al.
        Apolipoprotein E polymorphism modifies relation of hyperinsulinemia to hypertriglyceridemia.
        Diabetes. 1993; 42: 1474
        • Dong L-M
        • Yamamura T.
        • Yamamoto A.
        Enhanced binding activity of an apo E mutant, apo E5, to LDL receptors on human fibroblasts.
        Biochem Biophys Res Commun. 1990; 168: 409
        • Ehnholm C.
        • Lukka M.
        • Kuusi T.
        • et al.
        Apolipoprotein E polymorphism in the Finnish population: Gene frequencies and relation to lipoprotein concentrations.
        J Lipid Res. 1986; 27: 227
        • Eichner J.E.
        • Kuller L.H.
        • Orchard T.J.
        • et al.
        Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease.
        Am J Cardiol. 1993; 71: 160
        • Eto M.
        • Watanabe K.
        • Makino I.
        Increased frequencies of apolipoprotein e2 and e4 alleles in patients with ischemic heart disease.
        Clin Genet. 1989; 36: 183
        • Eto M.
        • Sato T.
        • Watanabe K.
        • et al.
        Effects of probucol on plasma lipids and lipoprotein in familial hypercholesterolemic patients with and without apolipoprotein E4.
        Atherosclerosis. 1990; 84: 49
        • Fisher E.A.
        • Blum C.B.
        • Zannis V.I.
        • et al.
        Independent effects of dietary saturated fat and cholesterol on plasma lipids, lipoproteins, and apolipoprotein E.
        J Lipid Res. 1983; 24: 1039
        • Gaddi A.
        • Ciarrocchi A.
        • Matteucci A.
        • et al.
        Dietary treatment for familial hypercholesterolemia—differential effects of dietary soy protein according to the apolipoprotein E phenotypes.
        Am J Clin Nutr. 1991; 53: 1191
        • Gåfvels M.E.
        • Caird M.
        • Britt D.
        • et al.
        Cloning of a cDNA encoding a putative human very low density lipoprotein/apolipoprotein E receptor and assignment of the gene to chromosome 9pter-p23.
        Somat Cell Mol Genet. 1993; 19: 557
        • Ghiselli G.
        • Schaefer E.J.
        • Gascon P.
        • et al.
        Type III hyperlipoproteinemia associated with plasma apolipoprotein E deficiency.
        Science. 1981; 214: 1239
        • Ghiselli G.
        • Gregg R.E.
        • Brewer H.B.
        Apolipoprotein EBethesda. Isolation and partial characterization of a variant of human apolipoprotein E isolated from very low density lipoproteins.
        Biochim Biophys Acta. 1984; 794: 333
        • Gregg R.E.
        • Zech L.A.
        • Schaefer E.J.
        • et al.
        Abnormal in vivo metabolism of apolipoprotein E4 in humans.
        J Clin Invest. 1986; 78: 815
        • Haffner S.M.
        • Kushwaha R.S.
        • Hazzard W.R.
        Metabolism of apolipoprotein B in members of a family with accelerated atherosclerosis: Influence of apolipoprotein E-3/E-2 pattern.
        Metabolism. 1992; 41: 241
        • Havel R.J.
        • Kane J.P.
        Primary dysbetalipoproteinemia: Predominance of a specific apoprotein species in triglyceride-rich lipoproteins.
        Proc Natl Acad Sci USA. 1973; 70: 2015
        • Havel R.J.
        • Kotite L.
        • Kane J.P.
        • et al.
        Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3.
        J Clin Invest. 1983; 72: 379
        • Havekes L.
        • de Wit E.
        • Leuven J.G.
        • et al.
        Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia.
        Hum Genet. 1986; 73: 157
        • Hill J.S.
        • Hayden M.R.
        • Frohlich J.
        • et al.
        Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia.
        Arterioscler Thromb. 1991; 11: 290
        • Hixson J.E.
        • P-DAY Research Group
        Apolipoprotein E polymorphism affects atherosclerosis in young males.
        Arterioscler Thromb. 1991; 11: 1237
        • Hopkins P.N.
        • Wu L.L.
        • Schumacher M.C.
        • et al.
        Type III hyperlipoproteinemia in patients heterozygous for familial hypercholesterolemia and apolipoprotein E2: Evidence for a gene-gene interaction.
        Arterioscler Thromb. 1991; 11: 1137
        • Jenkins D.J.A.
        • Hegele R.A.
        • Jenkins A.L.
        • et al.
        The apolipoprotein E gene and the serum low-density lipoprotein cholesterol response to dietary fiber.
        Metabolism. 1993; 42: 585
        • Jones P.J.H.
        • Dendy S.M.
        • Frohlich J.J.
        • et al.
        Cholesterol and triglyceride fatty acid synthesis in apolipoprotein E2-associated hyperlipidemia.
        Arterioscler Thromb. 1992; 12: 106
        • Kamboh M.I.
        • Aston C.E.
        • Ferrell R.E.
        • et al.
        Impact of apolipoprotein E polymorphism in determining interindividual variation in total cholesterol and low density lipoprotein cholesterol in Hispanics and non-Hispanic whites.
        Atherosclerosis. 1993; 98: 201
        • Koller W.C.
        • Glatt S.L.
        • Hubble J.P.
        • et al.
        Apolipoprotein E genotypes in Parkinson’s disease with and without dementia.
        Ann Neurol. 1995; 37: 242
        • Kurosaka D.
        • Teramoto T.
        • Matsushima T.
        • et al.
        Apolipoprotein E deficiency with a depressed mRNA of normal size.
        Atherosclerosis. 1991; 88: 15
        • Kuusi T.
        • Nieminen M.S.
        • Ehnholm C.
        • et al.
        Apoprotein E polymorphism and coronary artery disease: Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients.
        Arteriosclerosis. 1989; 9: 237
        • Lenzen H.J.
        • Assmann G.
        • Buchwalsky R.
        • et al.
        Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease.
        Clin Chem. 1986; 32: 778
        • Liddell M.
        • Williams J.
        • Bayer A.
        • et al.
        Confirmation of association between the e4 allele of apolipoprotein E and Alzheimer’s disease.
        J Med Genet. 1994; 31: 197
        • Lopez-Miranda J.
        • Ordovas J.M.
        • Mata P.
        • et al.
        Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol.
        J Lipid Res. 1994; 35: 1965
        • Mabuchi H.
        • Itoh H.
        • Takeda M.
        • et al.
        A young type III hyperlipoproteinemic patient associated with apolipoprotein E deficiency.
        Metabolism. 1989; 38: 115
        • Maeda H.
        • Nakamura H.
        • Kobori S.
        • et al.
        Identification of human apolipoprotein E variant gene: Apolipoprotein E7 (Glu244, 245→Lys244, 245).
        J Biochem. 1989; 105: 51
        • Maeda H.
        • Nakamura H.
        • Kobori S.
        • et al.
        Molecular cloning of a human apolipoprotein E variant: E5 (Glu3→Lys3).
        J Biochem. 1989; 105: 491
        • Mahley R.W.
        Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology.
        Science. 1988; 240: 622
        • Mahley R.W.
        • Rail S.C.
        Type III hyperlipoproteinemia (dysbetalipoproteinemia): The role of apolipoprotein E in normal and abnormal lipid metabolism.
        in: Scriver CR Beaudet AL Sly WS The Metabolic Basis of Inherited Diseases. ed 6. McGraw-Hill, New York1989: 1195
        • Mahley R.W.
        • Weisgraber K.H.
        • Innerarity T.L.
        • et al.
        Genetic defects in lipoprotein metabolism: Elevation of atherogenic lipoproteins caused by impaired catabolism.
        JAMA. 1991; 265: 78
        • Mänttäri M.
        • Koskinen P.
        • Ehnholm C.
        • et al.
        Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention.
        Metabolism. 1991; 40: 217
        • Martin L.J.
        • Connelly P.W.
        • Nancoo D.
        • et al.
        Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: Relationship to apolipoprotein E genotype.
        J Lipid Res. 1993; 34: 437
        • Mayeux R.
        • Stern Y.
        • Ottman R.
        • et al.
        The apolipoprotein e4 allele in patients with Alzheimer’s disease.
        Ann Neurol. 1993; 34: 752
        • McLean J.W.
        • Elshourbagy N.A.
        • Chang D.J.
        • et al.
        Human apolipoprotein E mRNA. cDNA cloning and nucleotide sequencing of a new variant.
        J Biol Chem. 1984; 259: 6498
        • Menzel H-J
        • Kladetzky R-G
        • Assmann G.
        Apolipoprotein E polymorphism and coronary artery disease.
        Arteriosclerosis. 1983; 3: 310
        • Miettinen T.A.
        • Gylling H.
        • Vanhanen H.
        Serum cholesterol response to dietary cholesterol and apoprotein E phenotype.
        Lancet. 1988; 2: 1261
        • Namba Y.
        • Tomonaga M.
        • Kawasaki H.
        • et al.
        Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer’s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.
        Brain Res. 1991; 541: 163
        • Nestruck A.C.
        • Bouthillier D.
        • Sing C.F.
        • et al.
        Apolipoprotein E polymorphism and plasma cholesterol response to probucol.
        Metabolism. 1987; 36: 743
        • Nieminen M.S.
        • Mattila K.J.
        • Aalto-Setala K.
        • et al.
        Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease.
        Arterioscler Thromb. 1991; 12: 58
        • Noguchi S.
        • Murakami K.
        • Yamada N.
        Apolipoprotein E genotype and Alzheimer’s disease.
        Lancet. 1993; 342: 737
        • O’Malley J.P.
        • Illingworth D.R.
        The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia.
        Metabolism. 1990; 39: 150
        • Orchard T.J.
        • Eichner J.
        • Kuller L.H.
        • et al.
        Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype. A report from the Multiple Risk Factor Intervention Trial.
        Ann Epidemiol. 1994; 4: 40
        • Ordovas J.M.
        • Litwack-Klein L.
        • Wilson P.W.F.
        • et al.
        Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoEl and apoE5 isoforms.
        J Lipid Res. 1987; 28: 371
        • Pedro-Botet J.
        • Sentí M.
        • Nogués X.
        • et al.
        Lipoprotein and apolipoprotein profile in men and ischemic stroke: Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism.
        Stroke. 1992; 23: 1556
        • Petersen R.C.
        • Smith G.E.
        • Ivnik R.J.
        • et al.
        Apolipoprotein E status as a predictor of the development of Alzheimer’s disease in memory-impaired individuals.
        JAMA. 1995; 273: 1274
        • Poirier J.
        • Davignon J.
        • Bouthillier D.
        • et al.
        Apolipoprotein E polymorphism and Alzheimer’s disease.
        Lancet. 1993; 342: 697
        • Rail S.C.
        • Weisgraber K.H.
        • Innerarity T.L.
        • et al.
        Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects.
        Proc Natl Acad Sci USA. 1982; 79: 4696
        • Rail S.C.
        • Weisgraber K.H.
        • Mahley R.W.
        Human apolipoprotein E: The complete amino acid sequence.
        J Biol Chem. 1982; 257: 4171
        • Rail S.C.
        • Weisgraber K.H.
        • Innerarity T.L.
        • et al.
        Identification of a new structural variant of human apolipoprotein E, E2(Lys146→Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype.
        J Clin Invest. 1983; 72: 1288
        • Rail S.C.
        • Newhouse Y.M.
        • Clarke R.G.
        • et al.
        Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant.
        J Clin Invest. 1989; 83: 1095
        • Richard P.
        • Thomas G.
        • de Zulueta M.P.
        • et al.
        Common and rare genotypes of human apolipoprotein E determined by specific restriction profiles of polymerase chain reaction-amplified DNA.
        Clin Chem. 1994; 40: 24
        • Saunders A.M.
        • Schmader K.
        • Breitner J.C.S.
        • et al.
        Apolipoprotein E e4 allele distributions in late-onset Alzheimer’s disease and in other amyloid-forming diseases.
        Lancet. 1993; 342: 710
        • Saunders A.M.
        • Strittmatter W.J.
        • Schmechel D.
        • et al.
        Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer’s disease.
        Neurology. 1993; 43: 1467
        • Savolainen M.J.
        • Rantala M.
        • Kervinen K.
        • et al.
        Magnitude of dietary effects on plasma cholesterol concentration: role of sex and apolipoprotein E phenotype.
        Atherosclerosis. 1991; 86: 145
        • Schachter F.
        • Faure-Delanef L.
        • Guénot F.
        • et al.
        Genetic associations with human longevity at the apoE and ACE loci.
        Nature Genetics. 1994; 6: 29
        • Schaefer E.J.
        • Gregg R.E.
        • Ghiselli G.
        • et al.
        Familial apolipoprotein E deficiency.
        J Clin Invest. 1986; 78: 1206
        • Sentí M.
        • Nogués X.
        • Pedro-Botet J.
        • et al.
        Lipoprotein profile in men with peripheral vascular disease: Role of intermediate density lipoproteins and apoprotein E phenotypes.
        Circulation. 1992; 85: 30
        • Sing C.F.
        • Davignon J.
        Role of apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation.
        Am J Hum Genet. 1985; 37: 268
        • Strittmatter W.J.
        • Saunders A.M.
        • Schmechel D.
        • et al.
        Apolipoprotein E: High avidity binding to ß-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
        Proc Natl Acad Sci USA. 1993; 90: 1977
        • Strittmatter W.J.
        • Weisgraber K.H.
        • Huang D.Y.
        • et al.
        Binding of human apolipoprotein E to synthetic amyloid ß peptide: Isoform-specific effects and implications for late-onset Alzheimer disease.
        Proc Natl Acad Sci USA. 1993; 90: 8098
        • Stuyt P.M.J.
        • Brenninkmeijer B.J.
        • Damacker P.N.M.
        • et al.
        Apolipoprotein E phenotypes, serum lipoproteins and apolipoproteins in angiographically assessed coronary heart disease.
        Scand J Clin Lab Invest. 1991; 51: 425
        • Tajima S.
        • Yamamura T.
        • Yamamoto A.
        Analysis of apolipoprotein E5 gene from a patient with hyperlipoproteinemia.
        J Biochem. 1988; 104: 48
        • Tajima S.
        • Yamamura T.
        • Menju M.
        • et al.
        Analysis of apolipoprotein E7 (apolipoprotein E-Suita) gene from a patient with hyperlipoproteinemia.
        J Biochem. 1989; 105: 249
        • Tikkanen M.J.
        • Huttunen C.
        • Ehnholm C.
        • et al.
        Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet.
        Arteriosclerosis. 1990; 10: 285
        • Ukkola O.
        • Kervinen K.
        • Salmela P.I.
        • et al.
        Apolipoprotein E phenotype is related to macro-and microangiopathy in patients with non-insulin-dependent diabetes mellitus.
        Atherosclerosis. 1993; 101: 9
        • Utermann G.
        • Hees M.
        • Steinmetz A.
        Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in man.
        Nature. 1977; 269: 604
        • Utermann G.
        • Hardewig A.
        • Zimmer F.
        Apolipoprotein E phenotypes in patients with myocardial infarction.
        Hum Genet. 1984; 65: 237
        • Utermann G.
        Apolipoprotein E polymorphism in health and disease.
        Am Heart J. 1987; 113: 433
        • van Bockxmeer F.M.
        • Mamotte C.D.
        Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease.
        Lancet. 1992; 340: 879
        • Vitale E.
        • Zuliani G.
        • Baroni L.
        • et al.
        Lipoprotein abnormalities in patients with extracoronary arteriosclerosis.
        Atherosclerosis. 1990; 81: 95
        • Wardell M.R.
        • Brennan S.O.
        • Janus E.D.
        • et al.
        Apolipoprotein E2-Christchurch (136Arg→Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia.
        J Clin Invest. 1987; 80: 483
        • Wardell M.R.
        • Rail S.C.
        • Schaefer E.J.
        • et al.
        Two apolipoprotein E5 variants illustrate the importance of the position of additional positive charge on receptor-binding activity.
        J Lipid Res. 1991; 32: 521
        • Warnick G.R.
        • Mayfield C.
        • Albers J.J.
        • et al.
        Gel isoelectric focusing method for specific diagnosis of familial hyperlipoproteinemia type 3.
        Clin Chem. 1979; 25: 279
        • Weisgraber K.H.
        • Rail S.C.
        • Mahley R.W.
        Human E apoprotein heterogeneity: cystiene-arginine interchanges in the amino acid sequence of the apo E isoforms.
        J Biol Chem. 1981; 256: 9077
        • Weisgraber K.H.
        • Innerarity T.L.
        • Mahley R.W.
        Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site.
        J Biol Chem. 1982; 257: 2518
        • Weisgraber K.H.
        • Rail S.C.
        • Innerarity T.L.
        • et al.
        A novel electrophoretic variant of human apolipoprotein E. Isolation and characterization of apolipoprotein El.
        J Clin Invest. 1984; 73: 1024
        • Weissfeld J.L.
        • Holloway J.J.
        Precision of blood cholesterol measurement and high blood cholesterol case-finding and treatment.
        J Clin Epidemiol. 1992; 45: 971
        • Wilson P.W.F.
        • Myers R.H.
        • Larson M.G.
        • et al.
        Apolipoprotein E alleles, dyslipidemia, and coronary heart disease: The Framingham offspring study.
        JAMA. 1994; 272: 1666
        • Wisniewski T.
        • Golabek A.
        • Matsubara E.
        • et al.
        Apolipoprotein E: binding to soluble Alzheimer’s ß-amyloid.
        Biochem Biophys Res Comm. 1993; 192: 359
        • Wu L.H.
        • Wu J.T.
        • Hopkins P.N.
        Apolipoprotein E: laboratory determination and clinical significance.
        in: Rifai N Warnick GR Laboratory Measurement of Lipids, Lipoproteins and Apolipoproteins. AACC Press, Washington DC1994: 279
        • Xhignesse M.
        • Lussier-Cacan S.
        • Sing C.F.
        • et al.
        Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health.
        Arterioscler Thromb. 1991; 11: 1100
        • Yamamoto A.
        • Yamamura T.
        • Tajima S.
        Risk factors for atherosclerotic vascular diseases with special reference to the relationship between apolipoprotein E mutations and hyperlipidemia.
        Ann NY Acad Sci. 1990; 598: 58
        • Yamamura T.
        • Yamamoto A.
        • Hiramori K.
        • et al.
        A new isoform of apolipoprotein E- Apo E5- associated with hyperlipidemia and atherosclerosis.
        Atherosclerosis. 1984; 50: 159
        • Yamamura T.
        • Yamamoto A.
        • Sumiyoshi T.
        • et al.
        New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.
        J Clin Invest. 1984; 74: 1229
        • Yamamura T.
        • Dong L.M.
        • Yamamoto A.
        Apolipoprotein E polymorphism and coronary heart disease.
        Chin Med J. 1992; 105: 738
        • Zannis V.I.
        • Cole F.S.
        • Jackson C.L.
        • et al.
        Distribution of apolipoprotein A-I, C-II, C-III, and E mRNA in fetal human tissues. Time-dependent induction of apolipoprotein E mRNA by cultures of human monocyte-macrophages.
        Biochem. 1985; 24: 4450
        • Zannis V.I.
        Molecular biology of human apolipoproteins B and E and associated diseases of lipoprotein metabolism.
        Adv Lipid Res. 1989; 23: 1
        • Zubenko G.S.
        • Stiffler S.
        • Stabler S.
        • et al.
        Association of the apolipoprotein E e4 allele with clinical subtypes of autopsy-confirmed Alzheimer’s disease.
        Am J Med Genet. 1994; 54: 199

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30290-7

      Copyright

      © 1996 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX